Literature DB >> 35108506

Selective vulnerabilities in the proteostasis network of castration-resistant prostate cancer.

Arielle Shkedi1, Isabelle R Taylor1, Frank Echtenkamp2, Poornima Ramkumar3, Mohamed Alshalalfa4, Génesis M Rivera-Márquez2, Michael A Moses2, Hao Shao1, Robert Jeffrey Karnes5, Len Neckers2, Felix Feng4, Martin Kampmann3, Jason E Gestwicki6.   

Abstract

Castration-resistant prostate cancer (CRPC) is associated with an increased reliance on heat shock protein 70 (HSP70), but it is not clear what other protein homeostasis (proteostasis) factors might be involved. To address this question, we performed functional and synthetic lethal screens in four prostate cancer cell lines. These screens confirmed key roles for HSP70, HSP90, and their co-chaperones, but also suggested that the mitochondrial chaperone, HSP60/HSPD1, is selectively required in CRPC cell lines. Knockdown of HSP60 does not impact the stability of androgen receptor (AR) or its variants; rather, it is associated with loss of mitochondrial spare respiratory capacity, partly owing to increased proton leakage. Finally, transcriptional data revealed a correlation between HSP60 levels and poor survival of prostate cancer patients. These findings suggest that re-wiring of the proteostasis network is associated with CRPC, creating selective vulnerabilities that might be targeted to treat the disease.
Copyright © 2022 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  chaperones; functional genomics; heat shock proteins; mitochondria; prostate cancer; proteostasis; shRNA

Mesh:

Substances:

Year:  2022        PMID: 35108506      PMCID: PMC8934263          DOI: 10.1016/j.chembiol.2022.01.008

Source DB:  PubMed          Journal:  Cell Chem Biol        ISSN: 2451-9448            Impact factor:   8.116


  74 in total

Review 1.  The Hsp70 and Hsp60 chaperone machines.

Authors:  B Bukau; A L Horwich
Journal:  Cell       Date:  1998-02-06       Impact factor: 41.582

2.  Genomic Hallmarks and Structural Variation in Metastatic Prostate Cancer.

Authors:  David A Quigley; Ha X Dang; Shuang G Zhao; Paul Lloyd; Rahul Aggarwal; Joshi J Alumkal; Adam Foye; Vishal Kothari; Marc D Perry; Adina M Bailey; Denise Playdle; Travis J Barnard; Li Zhang; Jin Zhang; Jack F Youngren; Marcin P Cieslik; Abhijit Parolia; Tomasz M Beer; George Thomas; Kim N Chi; Martin Gleave; Nathan A Lack; Amina Zoubeidi; Robert E Reiter; Matthew B Rettig; Owen Witte; Charles J Ryan; Lawrence Fong; Won Kim; Terence Friedlander; Jonathan Chou; Haolong Li; Rajdeep Das; Hui Li; Ruhollah Moussavi-Baygi; Hani Goodarzi; Luke A Gilbert; Primo N Lara; Christopher P Evans; Theodore C Goldstein; Joshua M Stuart; Scott A Tomlins; Daniel E Spratt; R Keira Cheetham; Donavan T Cheng; Kyle Farh; Julian S Gehring; Jörg Hakenberg; Arnold Liao; Philip G Febbo; John Shon; Brad Sickler; Serafim Batzoglou; Karen E Knudsen; Housheng H He; Jiaoti Huang; Alexander W Wyatt; Scott M Dehm; Alan Ashworth; Arul M Chinnaiyan; Christopher A Maher; Eric J Small; Felix Y Feng
Journal:  Cell       Date:  2018-10-18       Impact factor: 41.582

3.  Targeting the regulation of androgen receptor signaling by the heat shock protein 90 cochaperone FKBP52 in prostate cancer cells.

Authors:  Johanny Tonos De Leon; Aki Iwai; Clementine Feau; Yenni Garcia; Heather A Balsiger; Cheryl L Storer; Raquel M Suro; Kristine M Garza; Sunmin Lee; Yeong Sang Kim; Yu Chen; Yang-Min Ning; Daniel L Riggs; Robert J Fletterick; R Kiplin Guy; Jane B Trepel; Leonard M Neckers; Marc B Cox
Journal:  Proc Natl Acad Sci U S A       Date:  2011-07-05       Impact factor: 11.205

4.  Proteasome inhibitors in cancer therapy.

Authors:  Lisa J Crawford; Brian Walker; Alexandra E Irvine
Journal:  J Cell Commun Signal       Date:  2011-01-31       Impact factor: 5.782

5.  AR-V7 and resistance to enzalutamide and abiraterone in prostate cancer.

Authors:  Emmanuel S Antonarakis; Changxue Lu; Hao Wang; Brandon Luber; Mary Nakazawa; Jeffrey C Roeser; Yan Chen; Tabrez A Mohammad; Yidong Chen; Helen L Fedor; Tamara L Lotan; Qizhi Zheng; Angelo M De Marzo; John T Isaacs; William B Isaacs; Rosa Nadal; Channing J Paller; Samuel R Denmeade; Michael A Carducci; Mario A Eisenberger; Jun Luo
Journal:  N Engl J Med       Date:  2014-09-03       Impact factor: 91.245

6.  Global functional map of the p23 molecular chaperone reveals an extensive cellular network.

Authors:  Frank J Echtenkamp; Elena Zelin; Ellinor Oxelmark; Joyce I Woo; Brenda J Andrews; Michael Garabedian; Brian C Freeman
Journal:  Mol Cell       Date:  2011-07-22       Impact factor: 17.970

Review 7.  Hsp60, a novel target for antitumor therapy: structure-function features and prospective drugs design.

Authors:  Andrea Pace; Giampaolo Barone; Antonino Lauria; Annamaria Martorana; Antonio Palumbo Piccionello; Paola Pierro; Alessio Terenzi; Anna Maria Almerico; Silvestre Buscemi; Claudia Campanella; Francesca Angileri; Francesco Carini; Giovanni Zummo; Everly Conway de Macario; Francesco Cappello; Alberto J L Macario
Journal:  Curr Pharm Des       Date:  2013       Impact factor: 3.116

8.  The mutational landscape of lethal castration-resistant prostate cancer.

Authors:  Catherine S Grasso; Yi-Mi Wu; Dan R Robinson; Xuhong Cao; Saravana M Dhanasekaran; Amjad P Khan; Michael J Quist; Xiaojun Jing; Robert J Lonigro; J Chad Brenner; Irfan A Asangani; Bushra Ateeq; Sang Y Chun; Javed Siddiqui; Lee Sam; Matt Anstett; Rohit Mehra; John R Prensner; Nallasivam Palanisamy; Gregory A Ryslik; Fabio Vandin; Benjamin J Raphael; Lakshmi P Kunju; Daniel R Rhodes; Kenneth J Pienta; Arul M Chinnaiyan; Scott A Tomlins
Journal:  Nature       Date:  2012-07-12       Impact factor: 49.962

9.  Inhibition of de novo lipogenesis targets androgen receptor signaling in castration-resistant prostate cancer.

Authors:  Giorgia Zadra; Caroline F Ribeiro; Paolo Chetta; Yeung Ho; Stefano Cacciatore; Xueliang Gao; Sudeepa Syamala; Clyde Bango; Cornelia Photopoulos; Ying Huang; Svitlana Tyekucheva; Debora C Bastos; Jeremy Tchaicha; Brian Lawney; Takuma Uo; Laura D'Anello; Alfredo Csibi; Radha Kalekar; Benjamin Larimer; Leigh Ellis; Lisa M Butler; Colm Morrissey; Karen McGovern; Vito J Palombella; Jeffery L Kutok; Umar Mahmood; Silvano Bosari; Julian Adams; Stephane Peluso; Scott M Dehm; Stephen R Plymate; Massimo Loda
Journal:  Proc Natl Acad Sci U S A       Date:  2018-12-21       Impact factor: 11.205

10.  Hsp70 and Hsp40 inhibit an inter-domain interaction necessary for transcriptional activity in the androgen receptor.

Authors:  Bahareh Eftekharzadeh; Varuna C Banduseela; Giulio Chiesa; Paula Martínez-Cristóbal; Jennifer N Rauch; Samir R Nath; Daniel M C Schwarz; Hao Shao; Marta Marin-Argany; Claudio Di Sanza; Elisa Giorgetti; Zhigang Yu; Roberta Pierattelli; Isabella C Felli; Isabelle Brun-Heath; Jesús García; Ángel R Nebreda; Jason E Gestwicki; Andrew P Lieberman; Xavier Salvatella
Journal:  Nat Commun       Date:  2019-08-08       Impact factor: 17.694

View more
  2 in total

Review 1.  The mitochondrial unfolded protein response (UPRmt): shielding against toxicity to mitochondria in cancer.

Authors:  Joseph R Inigo; Dhyan Chandra
Journal:  J Hematol Oncol       Date:  2022-07-21       Impact factor: 23.168

Review 2.  Heat shock proteins: Biological functions, pathological roles, and therapeutic opportunities.

Authors:  Chen Hu; Jing Yang; Ziping Qi; Hong Wu; Beilei Wang; Fengming Zou; Husheng Mei; Jing Liu; Wenchao Wang; Qingsong Liu
Journal:  MedComm (2020)       Date:  2022-08-02
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.